Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox + Lovastatin Interaction
Contraindicatedinteraction on record
Description
Lipid-modifying Agents: HMG-CoA Reductase Inhibitors: lovastatin simvastatin ↑ lovastatin ↑ simvastatin Coadministration with lovastatin or simvastatin is contraindicated due to potential for serious reactions such as myopathy including rhabdomyolysis.
Source: FDA drug label - elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate